Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. The company is headquartered in Ponte Vedra, Florida. The company went IPO on 2021-04-23. The company is advancing the standard of care for the surgical management of bunion and related midfoot deformities. The company has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. The company has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. The company sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Mr. John Treace 2014 'den beri şirketle birlikte olan Treace Medical Concepts Inc 'in Chairman of the Board 'ıdır.
TMCI hissesinin fiyat performansı nasıl?
TMCI 'in mevcut fiyatı $1.21 'dir, son işlem günde 0% azalmış etti.
Treace Medical Concepts Inc için ana iş temaları veya sektörler nelerdir?
Treace Medical Concepts Inc Health Care endüstrisine ait ve sektör Health Care 'dir
Treace Medical Concepts Inc 'in piyasa değerlemesi nedir?
Treace Medical Concepts Inc 'in mevcut piyasa değerlemesi $78.1M 'dir
Treace Medical Concepts Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 6 analist Treace Medical Concepts Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 3 güçlü al, 4 al, 5 tut, 0 sat ve 3 güçlü sat içermektedir